There we will an incredible catalyst within 4 weeks or less, when CEO will likely provide preliminary results from first human inhalation QIXLEEF drug trial, used as a more effective pain killer than morphine (a multi billion dollar industry). Full trial will last 10 weeks.
In this chart I highlighted with red lines ehen the RSI was at 90 (as it is now). If you look at June, 2016 the RSI hit 90 but corrected as the pps continued to climb through Feb, 2017 going to over $1.00 before correcting. Important to me is the downtrend line which we tested yesterday and today. When we break it I will add to my position despite the overbought RSI https://stockcharts.com/h-sc/ui?s=TBPMF&p=D&yr=10&mn=3&dy=10&id=p03611140282&a=943308763&listNum=1
News 
Market Data 
Discover 
